Categories

Tag: Matthew Holt

#Healthin2Point00, Episode 240|Tebra, Notable, Wellinks, Aktiia, and Enlace Health

Today on Health in 2 Point 00, Jess and I talk briefly about Frontiers Health – frontiers.health – a digital health company with a deep therapeutics focus. Kareo and Patient Pop merge to form Tebra and get $65 million dollars from a PE firm. A notable raise from Notable, $100 million in a Series B brings to total up to $119 million. Wellinks gets $25 million in a Series C in the COPD space. Constant Blood Pressure monitoring company Aktiia gets $17.5 million, bringing their total up to $28 million. Aver Inc. rebrands, becoming Enlace Health, and raises 58 million dollars bringing their total up to $111 million. Investment efforts in Enlace were led by Cox Inc., and the relationship between Cox and Enlace seems very tight. -Matthew Holt

Matthew Holt

#Healthin2Point00, Episode 239: Hinge, Femtec, Science37, Augmedix

On a special Saturday edition of Health in 2 Point 00, Jess and I talk about her amazing forecasting and the huge scale of one deal. Yes, the Tiger pounces and Hinge Health takes its total raise to $1 billion. There’s also an complex combo deal for Femtec, raising $38m buying Birchbox and more, and we give a quick mention to the brief history of public companies Science 37 & Augmedix – Matthew Holt

#Healthin2Point00, Episode 238 | Truepill, Stride Health, Bardavon, and Wider Circle

Today on Health in 2 Point 00, Jess and I talk about the importance of a good company name. Some deals today: Truepill gets 142 million in a Series C bringing their valuation to 1.6 billion with 300 million ARR; Stride Health gets 47 million gets, bringing up their total to 86 million; Bardavon Health Innovations gets 90 million, bringing their total up to 109 million; Wider Circle gets 38 million, invested in by AmeriHealth Caritas. – Matthew Holt

THCB Gang Episode 70, Oct 28 1pm PT – 4pm ET

Joining Matthew Holt (@boltyboy) on THCBGang Thursday were policy consultant/author Rosemarie Day (@Rosemarie_Day1); Queen of all employer benefits related issues Jennifer Benz (@Jenbenz); ; fierce patient activist Casey Quinlan (@MightyCasey); and Suntra Modern Recovery CEO JL Neptune (@JeanLucNeptune).

With bills in Congress and billions in VC floating around health care, there was plenty of fodder for discussion. We also got into a robust discussion about Medicare Advantage versus traditional FFS. But just so happened that with Casey Quinlan H.U.M.A.N.Jennifer BenzJean-Luc Neptune, MD MBA & Rosemarie Day we had four people who are either cancer survivors or care givers for cancer patients or both. If you are Adam PellegriniGena CookLiz HorganMaya Said or anyone else who cares about helping people with cancer navigate the system the last 10 minutes of this are market research gold for you

You can see the video below and the audio will be on our podcast channel (Apple/Spotify) from Friday — Matthew Holt

#Healthin2Point 00, Episode 237 | Horowitz and Tiger Global, Medable, Zerigo Health, and more deals

Today on Health in 2 Point 00, Jess and I talk about Andreessen Horowtiz’s new ventures and the reemergence of Tiger Global in Health Tech. Some big deals for Episode 237: Medable receives 304 million in Series D bringing their total up to $521 million; Zerigo health gets $43 million, bringing their total up to $67 million; Click Therapeutics receives 52 million, but with side deals their total rises to $100 million; Workit Health gets $112 million, bringing their total to $138 million. Among Horowtiz’s new ventures, Patina gets 57 million despite not having launched yet, and Marley Medical gets $9 million. – Matthew Holt

#Healthin2Point 00, Episode 236 | HLTH 2021, Oak Street, 23andMe, Babylon Health, and Everlywell

Today on Health in 2 Point 00, Jess and I catch up after HLTH 2021. Some massive deals in Episode 356: Oak Street acquires Rubicon MD for 190 million, 130 in cash; 23andMe acquires Lemonade (a virtual care and drug delivery company) for 400 million – 300 million in stocks and 100 million in cash; Babylon Health’s SPAC deal, 4.2 billion in market cap now; Everlywell acquires Natalist – their third acquisition in 6 months. – Matthew Holt

THCB Gang Episode 69 – Thurs October 21 — Alex Drane Special!

I am so thrilled that as part of my East coast jaunt I got to do another special #THCBGang. This one is with the amazing Alex Drane, CEO of Archangels. Who among other things has almost singlehandedly changed the conversation about SDOH and lots more in this country. And you know that’s true because Jeff Goldsmith has said as much on #THCB Gang many times.

Listen to Alex’s career trajectory as an entrepreneur; how she discovered and publicized the “Unmentionaables“; the good and the bad of her leaving Eliza, and the incredibly important work she is doing with Archangels. All packed into 45 mins!

This is be available as a video below and a podcast on Apple and Spotify from Friday.

#Healthin2Point00, Episode 235 | Walgreens Health + VillageMD & CareCentrix, plus more deals

Today on Health in 2 Point 00, Noom launches a mental health offering, Noom Mood, Headspace partners with Waze to offer meditation while you drive, and we have one for the Press Release Hall of Fame where Dario Health announces a major partnership with a major national health plan— but doesn’t say who it is. We have some massive deals on Episode 235: Walgreens launches Walgreens Health, acquires a controlling stake of VillageMD, AND acquires a majority stake of CareCentrix; Intelerad acquires Ambra Health for $250 million; Mindbody acquires ClassPass; and Sprinter Health gets $33 million – even though their business model makes no sense. —Matthew Holt

THCB Gang Episode 67 – Thurs October 14

Joining Matthew Holt (@boltyboy) on THCBGang today were THCB regular writer Kim Bellard (@kimbbellard); patient safety expert and all around wit Michael Millenson (@MLMillenson); and privacy expert and entrepreneur Deven McGraw (@HealthPrivacy).

We heard a good bit from Deven about Ciitizen’s acquisition by genomic testing company Invitae, and got into it about the Texas abortion law, Walgreens moving into health care delivery in a big way–and whether the Giants can beat the Dodgers despite spending only 55% of their payroll! At least one of those questions will be answered tonight!

You can see the video below & if you’d rather listen than watch, the audio is preserved as a weekly podcast available on our iTunes & Spotify channels.

#Healthin2Point00, Episode 234 | An M&A and shedloads more money!

Today on Health in 2 Point 00, the word is SHEDLOAD. On Episode 235, Jess and I talk about the scoop on an M&A and shedloads more money in today’s health tech funding climate. First up, Lark gets $100 million, bringing its total to $185 million. How much more money can we throw at a chronic condition management platform? Next, Scottish remote patient monitoring company Current Health gets acquired by Best Buy. TrialSpark raises $156 million, working on developing drugs via their clinical trials software, Twin Health raises $140 million to run clinical trials in silico in “digital twins,” and virtual care GI company Oshi Health gets $23 million. —Matthew Holt

Registration

Forgotten Password?